Sopharma AD Logo

Sopharma AD

Develops, manufactures, and distributes pharmaceuticals and generics in Bulgaria and regional markets.

SFA | BSOBGN

Overview

Corporate Details

ISIN(s):
BG11SOSOBT18
LEI:
097900BGGW0000048796
Country:
Bulgaria
Address:
ул. Лъчезар Станчев 5, кула А, ет.18, 1756 София
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sopharma AD is a pharmaceutical company engaged in the development, manufacturing, and distribution of medicinal products and pharmaceutical substances. The company's operations encompass the entire value chain, from research and development, primarily focused on generics and new formulas, to the production and trade of a wide range of medications. As a leading pharmaceutical producer and distributor in Bulgaria, Sopharma also operates in regional markets like Serbia. The company's strategy is centered on providing high-quality, safe, and accessible treatments, with a business model focused on diversification, expansion, and sustainable development.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Sopharma AD and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-13 13:10
Transaction in Own Shares
Notification of sale of treasury shares
English 130.3 KB
2025-06-13 11:34
Director's Dealing
Notification from "Donev Investments Holding" AD in accordance with Regulation …
English 174.2 KB
2025-06-13 09:52
Director's Dealing
Notification from "Telso" AD in accordance with Regulation 596/2014 for transac…
English 185.4 KB
2025-06-12 13:42
Transaction in Own Shares
Notification of sale of treasury shares
English 129.1 KB
2025-06-12 12:38
Director's Dealing
Notification from Ognian Donev in accordance with Regulation 596/2014 for trans…
English 187.9 KB
2025-06-12 09:48
Director's Dealing
Notification from "Telso" AD in accordance with Regulation 596/2014 for transac…
English 182.1 KB
2025-06-11 14:29
Transaction in Own Shares
Notification of sale of treasury shares
English 129.6 KB
2025-06-11 13:57
Director's Dealing
Notification from Bissera Lazarova in accordance with Regulation 596/2014 for t…
English 188.7 KB
2025-06-11 12:21
Director's Dealing
Notification from "Telso" AD in accordance with Regulation 596/2014 for transac…
English 186.6 KB
2025-06-11 11:58
Director's Dealing
Notification from Ognian Donev in accordance with Regulation 596/2014 for trans…
English 192.9 KB
2025-06-10 16:04
Transaction in Own Shares
Notification of sale of treasury shares
English 130.4 KB
2025-06-10 14:58
Director's Dealing
Notification from Donev Investments Holding AD in accordance with Regulation 59…
English 184.3 KB
2025-06-10 14:42
Director's Dealing
Notification from "Telso" AD in accordance with Regulation 596/2014 for transac…
English 199.5 KB
2025-06-10 13:33
Director's Dealing
Notification from Ognian Donev in accordance with Regulation 596/2014 for trans…
English 191.0 KB
2025-06-09 15:46
Transaction in Own Shares
Notification of sale of treasury shares
English 130.0 KB

Automate Your Workflow. Get a real-time feed of all Sopharma AD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Sopharma AD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC

Talk to a Data Expert

Have a question? We'll get back to you promptly.